A radioimmurtoassay involving an 1251 ligand has been developed and applied to the measurement of urinary metanephrine.
A radioimmurtoassay involving an 1251 ligand has been developed and applied to the measurement of urinary metanephrine.
To validate the clinical usefulness of this assay, we compared measurement of metanephrine by radioimmunoassay and of total urinary metanephrines by the Pisano colorimetric method. The radioimmunoassay is specific for metanephrine, whereas the colorimetric method measures both metanephrine and normetanephrine. We used both methods to determine urinary metanephrine or totalmetanephrines in subjects with essential hypertension, pheochromocytoma, the syndrome of multiple endocrine adenomatosis type 2, and normotensive volunteers. The mean and upper limit of normal (3 SD) for metanephrine by radioimmunoassay inour normotensive volunteers was 94.2 tg/24 h and 229 g/24 h, respectively, which compares well with reported values of 87.6 zg/24 h and 319 tg/24 h by non-radioimmunoassay methods. Both radioimmunoassay and colorimetry accurately identified five patients with known pheochromocytoma. Good correlation (r = 0.993) was demonstrated between the two assays ina comparison of patients with essential hypertension and pheochromocytoma. We conclude that the radioimmunoassay isat leastequivalent to the colorimetric methods in distinguishing pathological and normal catecholamine secretion, and is faster, more precise,and 1000-foldmore sensitive.
AddItIonal Keyphrases: Pisano Of the four rabbits immunized, all produced titratable antiserum by the fourth booster immunization, but the highest-titer antiserum (final dilution 10 000) was the antiserum we used in this study.
Materials and Methods

Materials
lodination
The radioactive ligand, prepared by the Chloramine-T 
where A is the cpm precipitated at the various selected antisera dilutions, NSB is the nonspecific binding in cpm, and total is the total number of counts of i3Hlmetanephrine added to each tube (usually 10 000 cpm). When the %B reached 30% at 500-fold dilution, the antisera was characterized by determining sensitivity and cross reactivity with the 125! radioligand.
With use of excess antibody (100-fold final dilution), 80% of the ['251]3-iodosynephrine (10 000 cpm) could be bound within seven days after radioiodination. Figure 1 shows the difference in binding titers between [3Hjmetanephrine and ['251]3-iodosynephrine.
Radioimmunoassay Procedure
Because the [1251]3-iodosynephrine has much higher specific activity (1000-2000 kCi/mol) than the [3Hjmetanephrine, the %B vs antisera dilution (binding check) is repeated before each radioimmunoassay.
In general, a %B (or B0 in the competitive inhibition radioimmunoassay) of 30% can be obtained with a 10 000-fold final dilution of antisera.
Unlabeled synephrine, metanephrine, or other analogs were incubated for 30 mm with 150 ILL of diluted rabbit antiserum 1O5 and 50 AL of 0.1 mol/L EDTA at 37 #{176}C in the pH 7.5 phosphate buffer mixture described above, in a total volume of 1450 AL; then 10 000 cpm of [125I3-iodosynephrine was added in 50 AL of the buffer mixture and the incubation continued at 37 #{176}C for another 30 mm. Antibody-bound
[1251]3-iodosynephrine was then precipitated, along with 100 AL of a 250 mL/L solution of normal rabbit serum, by adding 1.5 mL of a solution of saturated ammonium sulfate. After centrifugation at 2400 rpm for 15 mm, the supernate was aspirated and radioactivity in the pellet counted with a gamma counter.
Extraction and Hydrolysis Procedure
To monitor extraction efficiencies, we added 10 000 cpm of [3H]methoxytyramine in 50 AL of 0.1 mol/L HC1 to 500-AL aliquots of urine. The pH of samples to be hydrolyzed was adjusted to 0.9 to 1.3 with 1 mol/L HC1; the mixture was heated in a boiling water bath for 30 mm, then cooled in an ice bath; and 500 AL of borate buffer (1.0 mol/L, pH 11) was added. The hydrolyzed metanephrine and the [2H]methoxytyramine were extracted into 10 mL of toluene/isoamyl alcohol (3/2 by vol) by vortex-mixing for 30s. The organic and aqueous phases were separated by low-speed centrifugation and 9.5 mL of the organic phase was transferred to tubes containing 500 AL of 50 mmol/L HC1. The metanephrine and [3H] methoxytyramine were extracted into the aqueous phase by vortex-mixing, after which the mixture was centrifuged. After the organic (top) phase was discarded, the aqueous phase was washed twice with 3 mL of water-saturated diethyl ether and the ether aspirated.
The small amount of ether remaining after aspiration was evaporated by exposing the aqueous phase to a stream of nitrogen at room temperature for 5 mm. A 100-AL aliquot of the aqueous phase was placed in a scintillation vial, mixed with 10 mL of Scintiverse, and its radioactivity counted with a scintillation counter. Five-to 50-AL aliquots were used directly in the radioimmunoassay. Urine pools with previously determined high, medium, and low concentrations of metanephrine (representing 20, 50, and 80% B/B0) were used to determine between-assay error; the pools were hydrolyzed and extracted before each determination. We assayed 100-AL aliquots of each extracted pool in seven different complete radioimmunoassay procedures and calculated between-assay error from the results. The within-assay coefficients of variation (CVs) at 80, 50, and 20% B/B0 were 13.6,9.9, and 7.3%, respectively.
The between-assay CVs at 80, 50, and 20% B/B0 were 37.0, 14.1, and 12.7%, respectively.
Most assays involved a 10 000-fold final dilution of antibody, producing a percent total binding of 33% (B0), which was Figure 3 . Metanephrine either added to urine before extraction and hydrolysis or in diluted pheochromocytoma urine was quantitatively recovered and displayed inhibition curves parallel to the standard buffer curve. The relative cross reactivities of the various compounds tested are listed in Table 1. The only significant  displacement  occurred with metanephrine, synephrine, and epinephrine. The 20% cross reactivity of synephrine was decreased to 5% with the extraction step, and the 12.8% cross reactivity of epinephrine was decreased to less than 10-%.
Results
We 
in a family with suspected-multiple endocrine adenomatosis type 2 ( Figure 5 ). Two members of the 14 family members tested had values above normal limits. One subject is hypertensive and was being treated with a-methyldopa.
His urine collection was repeated after stopping a-methyldopa for 14 days and although his blood pressure remained high, his urinary metanephrine (as determined by radioimmunoassay) decreased from 336 to 182 Ag/24 h. The second subject had significantly above-normal metanephrine excretion, 668 g/24 h, and was near the range of several of the patients presented with proven pheochromocytoma. Additional testing is in progress on this subject.
Discussion
The radioimmunoassay described is significantly more sensitive than colorimetric methods. The radioimmunoassay can detect urinary metanephrine in as little as 10 AL of normal human urine, whereas the colorimetric technique requires as much as 2.5 mL. The greatly increased sensitivity will allow quantitation of metanephrine in very small samples, such as might be obtained from neonates or small research animals. The radioimmunoassay is less time consuming and simpler than the colorimetric assay. By radioimmunoassay, one can easily analyze 400 samples per day, whereas more than 100 samples per day would be difficult by the colorimetric method, which requires multiple extractions, incubations, and manual quantitation with a spectrophotometer. The radioimmunoassay was at least equivalent to the Pisano method in its ability to differentiate patients with pheochromocytoma from hypertensive nonpheochromocytoma patients. Although the colorimetric method gave values almost ninefold higher than the radioimmunoassay, the former also measures normetanephrine, whereas the latter does not. The correlation between the two assays was excellent (r = 0.993) for samples analyzed in parallel (Figure 4 ). Several substances interfere in the measurement of total urinary metanephrine by the colorimetric technique. Some interact directly or are metabolized and converted to vanillin, which is the actual compound being measured colorimetrically. These compounds include isoproterenol, octopamine, and 4-hydroxybenzaldehyde
(1). We tested a large number of sympathomimetic amines and antihypertensive agents, none of which cross reacted in our assay (Table 1) . One patient ( Figure 5 ), while being treated with ct-methyldopa, had an increased value for metanephrine, but this returned to normal when the patient ceased taking a-methyldopa. Although neither cr-methyldopa nor any of its conceivable metabolites interfere with the radioimmunoassay itself, its effect in increasing endogenous metabolism of catecholamines can produce increased concentrations of metanephrine (6) . This drug-induced increase in urinary metanephrine may also be produced by other drugs that increase catecholamine turnover, including reserpine, phenoxybenzamine, and monoamine oxidase inhibitors (1, 7) . Therefore, we recommend that patients be as drug free as possible during testing.
The radioimmunoassay's specificity for metanephrine has both advantages and disadvantages. (9) . Therefore, it would be an extremely rare tumor that would not be detected by the metanephrine radioimmunoassay.
Fifty percent of neuroblastomas are also of nonadrenal origin. Because of the tendency of neuroblastoma to secrete more dopamine and its metabolites rather than normetanephrine, total urinary catecholamine measurements are more likely to detect this tumor than either the colorimetric method or the radioimmunoassay.
As is standard medical practice, when attempting to diagnose pheochromocytoma or neuroblastoma, a series of three urinary tests is usually performed, for metanephrine, VMA, and total catecholamines.
It is our contention that if the radioimmunoassay is used to replace the colorimetric method, the few cases of false negatives will not be overlooked if measurements of VMA and total catecholamines are also obtained.
The specificity of the metanephrine radioimmunoassay may be advantageous as an aid in distinguishing an adrenal from a nonadrenal pheochromocytoma. Although most all of these tumors secrete increased amounts of epinephrine (metanephrine), the ratio of urinary metanephrine to VMA by radioimmunoassay may be significantly higher in an adrenal tumor than in a nonadrenal tumor. This theoretical advantage of the metanephrine radioimmunoassay is totally beyond the scope of the colorimetric, VMA, or total catecholamine methods, alone or in combination. Stress-induced secretion of catecholamines in patients with essential hypertension can be difficult to distinguish from pheochromocytoma.
A technique of collecting urine for metanephrines from sleeping patients, to avoid stress-induced and postural increases in norepinephrine (normetanephrine) from the autonomic nervous system, has been reported (10 We conclude that the metanephrine radioimmunoassay is a reliable aid in the diagnosis of pheochromocytoma. Technically, the assay is significantly more rapid and 1000-fold more sensitive than the colorimetric method.
The marked specificity of the assay may help differentiate pheochromocytoma from essential hypertension, and help localize tumors.
